Please provide your email address to receive an email when new articles are posted on . This year marks the 20th year of Endocrine Today. Over the past 2 decades of the publication’s reporting on ...
LIVERPOOL— Many young people, most often from ethnically diverse or socially deprived backgrounds, are missing out on the potential benefits of diabetes technology through poor uptake, despite ...
Please provide your email address to receive an email when new articles are posted on . Diabetes care and education specialists can use a simple, three-step approach to optimize the way continuous ...
Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for ...
– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Control-IQ+ automated insulin delivery technology ...
Diabetes is one of the most common chronic health conditions in the United States. And for more than 30 million patients and their caretakers, diabetes medication and management can be a serious ...
Global disparities in access to insulin and diabetes technologies impact glycemic outcomes in children with type 1 diabetes. Centers with universal reimbursement for diabetes technologies achieve ...
In September 2020, DiabetesMine worked with a group of patient advocates to help shed light on the experiences of BIPOC (Black, Indigenous, and People of Color) with diabetes technology and care. What ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication of results from the Pediatric Artificial ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results